Antolimab (AK002)

An investigational monoclonal antibody selectively targeting Siglec-8, an inhibitory receptor found on mast cells and eosinophils

Eosinophilic Gastrointestinal Diseases (EGIDs)

Phase 2 study met all prespecified primary and secondary endpoints

Other Diseases

Clinical activity demonstrated in multiple mast cell and eosinophil driven diseases